<DOC>
	<DOCNO>NCT01459666</DOCNO>
	<brief_summary>Evaluate efficacy safety use aboBTX-A improve wound heal prior Mohs micrographic surgery reconstruction skin cancer forehead</brief_summary>
	<brief_title>Forehead Scars Following Mohs Micrographic Surgery Reconstruction Skin Cancer</brief_title>
	<detailed_description>- Outcomes Patient Observer Assessment Scale ( POSAS ) , Visual Analog Scale , Patient Satisfaction Survey . - Study consist 5 clinic visit approximately 6 month</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Have biopsy prove skin cancer forehead amenable Mohs surgery Undergoing elective reconstruction biopsy proven skin cancer amenable Mohs surgery defect size measure 1.0 cm great If female , currently pregnant , currently breastfeed , potential pregnancy , childbearing age , agree use birth control . Agrees use disallow concomitant medication ( retinoids ) agree use sunscreen forehead area duration study Current past history neuromuscular disease ( myasthenia gravis , amyotrophic lateral sclerosis , EatonLambert syndrome ) History radiation therapy chemotherapy History keloid hypertrophic scar formation Has use botulinum toxin forehead area within one year . Has use topical retinoids forehead area within past 4 week Any hypersensitivity component abobotulinumtoxinA ( i.e . cow milk protein ) previous hypersensitivity botulinum toxin A related product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Scar</keyword>
	<keyword>Forehead</keyword>
	<keyword>Skin Cancer</keyword>
	<keyword>MOHS Surgery</keyword>
	<keyword>Dermatology</keyword>
</DOC>